Cochlear’s Baha 6 Max Receives FDA Clearance
Cochlear Limited (ASX: COH) announced the Food and Drug Administration (FDA)'s clearance of the new Cochlea Baha 6 Max Sound Processor, designed to “improve hearing outcomes for people with SSD (single-sided deafness), conductive or mixed hearing loss.”
